Abrysvo, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
7680696910017
CH-69691
Pulver
Associated product:
ABRYSVO subst sèche 120 mcg c solv ser pré
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
A
|
0.06 MG | Substance | Wirkstoff (Principe actif) |
|
B
|
- | Substance | HNIDK |
|
A
|
0.06 MG | Substance | Wirkstoff (Principe actif) |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
0.433 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 185.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2025
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69691
- Drug name
- Abrysvo, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULIL
- ATC Code
- J07BX
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 23/08/2024
- Authorization expiration date
- 22/08/2029
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- ABRYSVO subst sèche 120 mcg c solv ser pré
- Description (DE)
- ABRYSVO Trockensub 120 mcg c Solv Fertspr
- Market launch
- 23/08/2024
- Narcotic (BTM)
- No